"Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Letter]." Journal of Multidisciplinary Healthcare, , pp. 1393–1394
View responses to this article:
Disclosure
All author reports no other conflict of interest in this communication.